1. Home
  2. ONFO vs SILO Comparison

ONFO vs SILO Comparison

Compare ONFO & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onfolio Holdings Inc.

ONFO

Onfolio Holdings Inc.

HOLD

Current Price

$0.55

Market Cap

3.3M

Sector

Technology

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.32

Market Cap

3.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONFO
SILO
Founded
2018
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Apparel
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.9M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
ONFO
SILO
Price
$0.55
$0.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.7K
277.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.83
EPS
N/A
N/A
Revenue
N/A
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.22
52 Week High
$1.95
$1.44

Technical Indicators

Market Signals
Indicator
ONFO
SILO
Relative Strength Index (RSI) N/A 52.11
Support Level N/A $0.33
Resistance Level N/A $0.47
Average True Range (ATR) 0.00 0.04
MACD 0.00 0.00
Stochastic Oscillator 0.00 83.15

Price Performance

Historical Comparison
ONFO
SILO

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: